PHARMAWRITE - Key Persons
We are pleased to announce that Danielle Ippolito, PhD, CMPP has joined the Science Team at PharmaWrite Medical Communications and MedVal Scientific Information Services as a researcher and medical writer.
Dr. Ippolito, an award-winning research scientist, writer, and presenter, brings to PharmaWrite and MedVal nearly 25 years of experience in toxicology, pharmacology, maternal-fetal medicine, gestational diabetes, military medicine, reproductive health, chronic pain management, opioid addiction, and diagnostic devices. She has also authored oncology press releases for a major cancer research center and conducted basic research in breast cancer. Much of her work has focused on proteomics, an innovative diagnostic field in which proteins and other biomarkers within the blood are used to assess overall patient health and diagnose disease.
Dr. Ippolito has won 10 awards for excellence in research, including 2 awards for best manuscript. She has authored 35 peer-reviewed articles in journals such as Journal of Occupational and Environmental Medicine, Toxicology and Applied Pharmacology, Molecular & Cellular Proteomics, American Journal of Obstetrics & Gynecology, Molecular Systems Biology, Journal of Neuroscience, Neuron, and Journal of Surgical Research, among others. She has presented widely at scientific congresses and has coordinated and written clinical and preclinical protocols, patent applications for in vitro diagnostic assays, and gap analyses in support of military medical products. During her 11-year tenure with the US Army at Ft. Detrick, MD and Joint Base Lewis-McChord, WA, Dr. Ippolito managed a $3.3M medical research budget and provided scientific leadership for 11 personnel. As the Director of Research for the Maternal-Fetal Medicine Division at Madigan Army Medical Center, she served on the Institutional Review Board (IRB) and was mentor and/or thesis advisor for 26 fellows and students.
Dr. Ippolito has earned certificates in medical writing and regulatory writing and a certification in Science & Technology Management, and is a reviewer for multiple peer-reviewed publications. She is a Regional Coordinator and member of the American Medical Writers Association and a member of the DC Science Writers Association, and has received the Certified Medical Publication Professional certification. Dr. Ippolito holds a PhD in Pharmacology from the University of Washington-Seattle, with a dissertation on pharmacological targets for opioid drugs used in chronic pain management. She earned her Bachelor of Science degree in Pharmacology/Toxicology with a double-major in English from the University of Wisconsin-Madison.
Dr. Megan McEntire's current role as Associate Director of Scientific Communications enables her to interact with clients and key opinion leaders on a personal basis to facilitate dissemination of medical knowledge. Megan has experience in publication planning, developing scientific manuscripts, planning and implementing scientific development and logistics for advisory board meetings, competitive surveillance reporting, and conducting gap analyses and KOL analyses in the therapeutic areas of pain management, women's health, bipolar disorder, rheumatoid arthritis, osteoporosis, infectious disease, rare diseases, and oncology. As the fellowship director, she ensures that the fellows receive a well-rounded education in medical publications with as much hands on experience as possible. She also serves as the primary preceptor for APPE PharmD students from Albany College of Pharmacy and Health Sciences, Rutgers University, Temple University, and the University of the Sciences in Philadelphia.
Megan graduated from East Tennessee State University with a Bachelor of Science in Chemistry, concentration in Biochemistry, and worked in the chemical industry. However, her passion was to help people in the healthcare field, so she returned to further her education at the Bill Gatton College of Pharmacy at East Tennessee State University, where she received her Doctor of Pharmacy degree in 2011.
Megan completed the 2011-2012 PharmaWrite/MedVal Medical Communications Postdoctoral fellowship program. She was the first fellow to obtain her teaching certificate from the University of the Sciences College of Pharmacy in Philadelphia. In 2012 she joined PharmaWrite as an Associate Manager of Scientific Communications and in 2013 she received her Certified Medical Publication Professional (CMPP) credential through ISMPP. Megan is a member of APhA, ASHP, AMWA, IPhO, and ISMPP and serves on the ISMPP Membership Committee.
Job Titles:
- Medical Director
- Pharmacologist
Dr. Edward Weselcouch is a pharmacologist who has spent his career within the pharmaceutical and medical device industries in both large and small companies. The depth of his background allows him to participate in all phases of project development at PharmaWrite, where his primary responsibilities include the preparation of scientific articles for publication in medical journals, the creation of presentation materials, and the supervision of work of other medical writers.
Dr. Weselcouch's broad foundation in pharmacology was acquired at The Upjohn Company and Bristol-Myers Squibb and includes areas such as autonomic pharmacology (calcium channels, adrenergic receptors), vascular biology (arterial thrombosis, prevention of restenosis), and treatment of myocardial ischemia, peripheral vascular disease, and stroke. He also has experience in the medical device arena, having served as a principal scientist in the development of a catheter-based local drug delivery system at Focal, Inc. Most recently, Dr. Weselcouch served as the Director of Pharmacology at InfiMed Therapeutics, Inc., where he supervised the in vitro and in vivo evaluation and development of the company's technology for sustained-release dosing of protein drugs and participated in the preparation of an IND submission for the company's first product. In addition, he served as the company's scientific spokesman during domestic and international partnering and financing activities.
At PharmaWrite, Dr. Weselcouch has broadened his experience by serving as the primary writer for two rare genetic metabolic disorders, and in that role worked successfully with international physicians from diverse therapeutic areas. Most recently he has worked on three distinct pain products, including opioid, non-opioid, and topical analgesics. Other therapeutic areas that he has contributed to include treatment and consequences of hypertension, cardiovascular complications of diabetes, chronic occlusive pulmonary disease, women's health, and treatment of childhood epilepsy. Dr. Weselcouch earned his PhD in Pharmacology at Dartmouth College. He is a past member of the American Society of Pharmacology and Experimental Therapeutics, the Microvascular Society, and the American Society of Hypertension.
Lou Greco came to PharmaWrite with a strong background in pharmaceutical science and management from his tenure at Rutgers University College of Pharmacy and in retail pharmacy. Lou's primary responsibilities at PharmaWrite begin with providing clients with strategic direction and advocacy development (eg, recruiting and building relationships with opinion leaders). As well, he manages multiple teams of talented writers, researchers, project managers, editors, meeting planners, and artists in developing and initiating scientific communications platforms, product publication plans, advisory board meetings, AMCP dossiers, product monographs, and several other types of meetings and publications. He also plays a key role in PharmaWrite's business development strategy and development of new offerings.
In 2011, Lou was also named Executive Vice President of Jobson Medical Information, the previous parent company of PharmaWrite. As such, Lou worked with the corporate executive team to develop and manage corporate strategy, objectives, and finances.
In 2009, Lou assumed the role of Managing Director of PharmQD.com, a pharmacy social and professional network. His responsibilities include overseeing network launch, handling P&L, and coordinating marketing tactics, technology, and content development across the network.
Lou received his Bachelor of Science degree in Pharmacy from Rutgers University College of Pharmacy in Piscataway, New Jersey. He returned to the College of Pharmacy to earn his Doctor of Pharmacy degree in 2001. Prior to joining PharmaWrite, Lou was Director of the Office of Continuous Education at Rutgers, where he served as Adjunct Professor in the Department of Pharmacy Practice and Administration. He has also worked in the field as a Pharmacist-in-Charge and staff pharmacist at a number of pharmacies in New Jersey. His management skills have been refined over the years through his work on various academic and experiential committees at Rutgers University.
Currently, Lou is working to earn his graduate certificate in Pharmaceutical and Medical Device Law and Compliance at the Seton Hall School of Law in New Jersey. Lou is a member of the International Society of Medical Publication Professionals (ISMPP), currently serving on the Membership Committee.
Job Titles:
- Director of Scientific Communications at Pharma
Robert Gilbert, Director of Scientific Communications at PharmaWrite, has an uncommon commitment to quality and client satisfaction. His 19 years of experience with PharmaWrite have included management of 20 pub plans for 27 products (7 launch; 5 line extensions) for 14 pharmaceutical companies. This work has included successful publications in JAMA, The Lancet, Annals of Internal Medicine, The Journal of Family Practice, and many top-tier specialist journals.
Robert has also managed over 50 advisory board, speaker training, and regional consultant meetings. In addition, he has managed multidisciplinary summits with specialists, PCPs, nurses, NPs/PAs, claims processing/office managers, patients, and MCO representatives, as well as numerous CE symposia, including a series of 10 multidisciplinary CE meetings for 2,000 physicians, nurses, and pharmacists.
Robert has also written regulatory reports submitted to the US Food and Drug Administration and facilitated workshops on medical writing for clinical investigators and on creating presentations for medical liaisons. He has also directed the creation of clinical and caregiver websites for patient advocacy organizations and assisted them in the identification of thought leaders, with a special focus on identifying specialist "up & comers" through analysis of recent abstract submissions. Robert has also overseen the creation of medical response letters, AMCP Dossiers, formulary kits, and international scientific product monographs for launch products, and he has helped develop speakers bureau websites and facilitated live and archived speaker training webcasts.
Robert's academic experience enables him to establish an easy rapport with investigators and other members of the academic and scientific community, resulting in relationships that prove to be highly effective in meeting the needs of PharmaWrite's clients. Since joining the PharmaWrite team, Rob has worked in the areas of analgesia (adult and pediatric) for both acute and chronic conditions (eg, low back pain, osteoarthritis, fibromyalgia, neuropathic pain, sports injuries), drug abuse, epilepsy, anti-infectives, hypophosphatasia, and metabolic disorders. He is a Certified Medical Publication Professional and member of the International Society for Medical Publication Professionals (ISMPP), the International Publication Planning Association (TIPPA), and an associate member of the Committee on Publication Ethics (COPE).
Robert studied in Europe for 8 years and remains proficient in French, German, and Dutch. His academic expertise is in text hermeneutics, classical literary theory, and several ancient languages (Greek, Latin, Hebrew, Aramaic, Moabitic). Robert currently lives in Hunterdon County in New Jersey with his wife, Diane, and two children, Michael and Daniel.
As Managing Director of PharmaWrite, Rosie Lynch is in charge of expanding the organization's strategic vision, developing new business, maintaining thought leader relationships, and managing strategic alliances with other members of the Jobson family of companies. Rosie has over 20 years of medical communications experience developing educational, strategic, and tactical initiatives for the pharmaceutical industry. She was CEO and President at another Jobson company for 8 years and Vice President of Scientific Affairs for 8 years, where she oversaw the development and execution of a wide variety of medical communications programs across all phases of brand lifecycles. Rosie's marketing and business development expertise, scientific background, and managerial skills have enabled her to design and implement programs with proven return on investment. She was responsible for starting the pharmacy internship program through Rutgers College of Pharmacy many years ago.
Rosie earned her Bachelor of Science degree at Rutgers University College of Pharmacy and is licensed to practice pharmacy in New Jersey and Pennsylvania. She is a lifelong member of the, the Hematology Oncology Pharmacists Association (HOPA). She recently completed serving a 3-year term on the Board of Trustees of the International Society for Medical Publication Professionals (ISMPP) as Treasurer. Rosie is a Certified Medical Publications Professional (CMPP).
Rosie began her career at Schering in Drug Information, where she handled all healthcare-related inquiries and provided training to the sales force on key medical components of their sales areas. She then moved into professional services in respiratory and allergy medicine. Rosie also worked in marketing development at Schering, where she was involved in the highly successful launch of Claritin.